LKB1/AMPK Pathway and Drug Response in Cancer: A Therapeutic Perspective

Inactivating mutations of the tumor suppressor gene Liver Kinase B1 (LKB1) are frequently detected in non-small-cell lung cancer (NSCLC) and cervical carcinoma. Moreover, LKB1 expression is epigenetically regulated in several tumor types. LKB1 has an established function in the control of cell metab...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciccarese, Francesco, Zulato, Elisabetta, Indraccolo, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874879/
https://www.ncbi.nlm.nih.gov/pubmed/31781355
http://dx.doi.org/10.1155/2019/8730816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874879/
https://www.ncbi.nlm.nih.gov/pubmed/31781355
http://dx.doi.org/10.1155/2019/8730816

Ejemplares similares